We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 27, 2020

Effect of Concomitant Medications With Immunomodulatory Properties on Outcomes in Advanced Cancer Treated With Immune Checkpoint Inhibitors

European Journal of Cancer


Additional Info

European Journal of Cancer
Effect of Concomitant Medications With Immune-Modulatory Properties on the Outcomes of Patients With Advanced Cancer Treated With Immune Checkpoint Inhibitors: Development and Validation of a Novel Prognostic Index
Eur. J. Cancer 2021 Jan 01;142(xx)18-28, S Buti, M Bersanelli, F Perrone, M Tiseo, M Tucci, V Adamo, LS Stucci, A Russo, ET Tanda, F Spagnolo, F Rastelli, F Pergolesi, D Santini, M Russano, C Anesi, R Giusti, M Filetti, P Marchetti, A Botticelli, A Gelibter, MA Occhipinti, M Ferrari, MG Vitale, L Nicolardi, R Chiari, E Rijavec, O Nigro, A Tuzi, M De Tursi, P Di Marino, F Conforti, P Queirolo, S Bracarda, S Macrini, S Gori, F Zoratto, E Veltri, B Di Cocco, D Mallardo, MG Vitale, M Santoni, L Patruno, G Porzio, C Ficorella, DJ Pinato, PA Ascierto, A Cortellini

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading